本页面由Tiger Trade Technology Pte. Ltd.提供服务

Artelo Biosciences, Inc.

1.90
+0.04002.15%
成交量:10.55万
成交额:19.86万
市值:383.56万
市盈率:-0.10
高:1.94
开:1.85
低:1.79
收:1.86
52周最高:28.60
52周最低:1.52
股本:201.87万
流通股本:180.54万
量比:0.03
换手率:5.85%
股息:- -
股息率:- -
每股收益(TTM):-18.9641
每股收益(LYR):-18.2923
净资产收益率:-436.14%
总资产收益率:-136.26%
市净率:-6.06
市盈率(LYR):-0.10

数据加载中...

2021/02/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/01/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/04

重要事件披露

8-K - Current report
2020/12/02

重要事件披露

8-K - Current report
2020/11/20

重要事件披露

8-K - Current report
2020/11/04

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/10/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/14

重要事件披露

8-K - Current report
2020/10/08

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/07

SEC问询函

CORRESP [Cover] - Correspondence